![]() |
市场调查报告书
商品编码
1503369
至 2030 年慢性伤口护理市场预测 - 按产品(高级伤口敷料、治疗设备、主动伤口护理和其他产品)、伤口类型、最终用户和地理位置进行的全球分析Chronic Wound Care Market Forecasts to 2030 - Global Analysis By Product (Advanced Wound Dressings, Therapy Devices, Active Wound Care and Other Products), Wound Type, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球慢性伤口护理市场规模为 154.3 亿美元,预计到 2030 年将达到 220.2 亿美元,预测期内复合年增长率为 8.6%。慢性伤口护理涉及对未能在预期时间范围内(通常超过三个月)正常癒合阶段进行的伤口的治疗和管理。有效的慢性伤口照护包括彻底评估、清创、控制感染、水分平衡和解决潜在问题。它通常需要多学科方法,整合先进疗法、病患教育和持续监测,以促进癒合并预防併发症。
根据医疗保健研究与品质机构的数据,美国每年有超过 250 万人患有压疮。
糖尿病和肥胖症发生率上升
由于癒合过程受损和免疫力下降,糖尿病患者和肥胖者更容易出现慢性伤口,例如溃疡和感染。因此,对先进伤口护理产品和疗法以有效管理这些病症的需求不断增加。需求的激增推动了慢性伤口护理市场的创新和扩张,促进了专业治疗和技术的发展,以满足不断增长的患者需求。
发展中地区的认知有限
发展中地区对慢性伤口护理的认识有限,往往是由于医疗保健专业人员缺乏教育和培训、公共卫生倡议不足以及获得先进医疗技术的机会有限。这种认知的缺乏导致诊断和治疗不足,延长患者的痛苦并增加医疗费用。因此,由于对先进伤口护理产品和服务的需求仍然较低,市场成长受到阻碍,阻碍了这些地区的投资和创新。
政府支持倡议
政府的支持性措施为研究和开发提供资金,确保更好的医疗基础设施,并提高患者获得先进治疗的机会。这些改善了临床结果,同时监管部门的批准加快了创新伤口护理产品的上市。此外,报销计划减轻了患者的经济负担,并鼓励使用先进的伤口护理疗法。这些共同努力为慢性伤口护理解决方案的市场扩张和创新创造了有利的环境。
治疗费用高
由于癒合时间长、需要专门的治疗、频繁的就诊和先进的伤口护理产品,慢性伤口护理的治疗成本很高。这些成本对于医疗保健系统和患者来说可能是巨大的,导致财务紧张。此外,慢性伤口的复杂性需要持续创新,这进一步增加了成本并为市场扩张造成了障碍。
Covid-19 影响
covid-19 大流行扰乱了供应链、推迟了择期手术以及将医疗资源转移到紧急应变上,从而对慢性伤口护理市场产生了重大影响。许多患者获得常规护理的机会减少,导致伤口状况恶化。然而,它也加速了远距医疗和远端监控技术的采用,加强了慢性伤口的管理。总体而言,这场大流行凸显了针对慢性病建立有弹性和适应性的医疗保健系统的必要性。
治疗设备领域预计将在预测期内成为最大的领域
治疗设备领域预计将出现利润丰厚的成长。治疗设备有助于伤口癒合和管理,在慢性伤口护理中发挥着至关重要的作用。这些设备包括负压伤口治疗系统、高压氧舱、电刺激设备和超音波设备。它们具有多种治疗功效,例如促进血液循环、减少细菌负荷、增强组织再生和维持湿润的伤口环境。有效使用治疗设备对于改善慢性伤口患者的治疗效果和加速其癒合过程至关重要。
预计糖尿病足溃疡部分在预测期内复合年增长率最高
预计糖尿病足溃疡部分在预测期内复合年增长率最高。糖尿病足溃疡的慢性伤口护理着重于管理和治癒这些复杂伤口的专门治疗。它涉及多学科方法,包括清创、卸载、感染控制和根据糖尿病患者需求量身定制的先进敷料。治疗介入措施旨在预防感染和截肢等併发症,促进更快的康復并提高生活品质。定期监测和病患教育对于有效管理糖尿病足溃疡和预防復发至关重要。
由于人口老化、糖尿病和肥胖症盛行率上升以及医疗保健意识不断提高,预计亚太地区在预测期内将占据最大的市场份额。中国、印度和日本等国家凭藉其庞大的患者群体和不断扩大的医疗基础设施正在推动市场成长。在政府措施和不断增加的医疗支出的支持下,先进伤口护理产品和技术的采用也在增加。
由于其先进的医疗基础设施,预计北美在预测期内的复合年增长率最高。美国和加拿大在创新伤口护理产品和技术的研发方面投入大量资金,引领市场。强有力的报销政策、广泛的意识以及主要市场参与者的存在进一步支持了成长。此外,该地区人口老化以及糖尿病和肥胖症的高盛行率推动了市场的成长。
2023 年 5 月,3M 已达成协议,将总部位于德国塞费尔德的牙科局部麻醉产品组合相关的某些资产出售给全球製药业服务提供商 Pierrel SpA(「Pierrel」),以换取收购价格为7000 万美元,有待成交和其他调整。
2023年1月,Mimedx与Gunze Medical Limited签订了独家经销协议,在日本销售用于伤口癒合的胎盘组织同种异体移植物Epifix。根据该协议,该公司旨在加强其在日本市场的地位。
According to Stratistics MRC, the Global Chronic Wound Care Market is accounted for $15.43 billion in 2024 and is expected to reach $22.02 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Chronic wound care involves the treatment and management of wounds that fail to progress through the normal stages of healing within an expected timeframe, typically over three months. Effective chronic wound care includes thorough assessment, debridement, infection control, moisture balance, and addressing underlying conditions. It often requires a multidisciplinary approach, integrating advanced therapies, patient education, and continuous monitoring to promote healing and prevent complications.
According to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year.
Rising incidence of diabetes and obesity
Diabetic patients and obese individuals are more prone to chronic wounds such as ulcers and infections due to impaired healing processes and reduced immunity. Consequently, there is a heightened demand for advanced wound care products and therapies to manage these conditions effectively. This surge in demand drives innovation and expansion within the chronic wound care market, fostering the development of specialized treatments and technologies to address the increasing patient needs.
Limited awareness in developing regions
Limited awareness of chronic wound care in developing regions is often due to a lack of education and training among healthcare professionals, insufficient public health initiatives, and limited access to advanced medical technologies. This lack of awareness results in inadequate diagnosis and treatment, prolonging patient suffering and increasing healthcare costs. Consequently, the market growth is hampered as the demand for advanced wound care products and services remains low, hindering investments and innovations in these regions.
Supportive government initiatives
Supportive government initiatives provide funding for research and development, ensuring better healthcare infrastructure, and enhancing patient access to advanced treatments. These improve clinical outcomes, while regulatory approvals expedite the availability of innovative wound care products. Additionally, reimbursement schemes reduce the financial burden on patients, encouraging the use of advanced wound care therapies. These combined efforts foster a conducive environment for market expansion and innovation in chronic wound care solutions.
High treatment costs
Chronic wound care has high treatment costs due to prolonged healing times, the need for specialized treatments, frequent medical visits, and advanced wound care products. These costs can be substantial for healthcare systems and patients, leading to financial strain. Additionally, the complexity of chronic wounds demands continuous innovations, further escalating costs and creating barriers for market expansion.
Covid-19 Impact
The covid-19 pandemic significantly impacted the chronic wound care market by disrupting supply chains, delaying elective procedures, and shifting healthcare resources to emergency responses. Many patients experienced reduced access to routine care, exacerbating wound conditions. However, it also accelerated the adoption of telemedicine and remote monitoring technologies, enhancing chronic wound management. Overall, the pandemic highlighted the need for resilient and adaptable healthcare systems for chronic conditions.
The therapy devices segment is expected to be the largest during the forecast period
The therapy devices segment is estimated to have a lucrative growth. Therapy devices play a crucial role in chronic wound care by aiding in wound healing and management. These devices include negative pressure wound therapy systems, hyperbaric oxygen chambers, electrical stimulation devices, and ultrasound devices. They provide various therapeutic benefits such as promoting blood circulation, reducing bacterial load, enhancing tissue regeneration, and maintaining a moist wound environment. Effective use of therapy devices is essential in improving outcomes and accelerating the healing process for patients with chronic wounds.
The diabetic foot ulcers segment is expected to have the highest CAGR during the forecast period
The diabetic foot ulcers segment is anticipated to witness the highest CAGR growth during the forecast period. Chronic wound care for diabetic foot ulcers focuses on specialized treatments to manage and heal these complex wounds. It involves a multidisciplinary approach including debridement, offloading, infection control, and advanced dressings tailored to diabetic patient's needs. Therapeutic interventions aim to prevent complications like infections and amputations, promoting faster healing and improved quality of life. Regular monitoring and patient education are crucial in managing diabetic foot ulcers effectively and preventing recurrence.
Asia Pacific is projected to hold the largest market share during the forecast period due to aging population, increasing prevalence of diabetes and obesity, and rising healthcare awareness. Countries like China, India, and Japan are driving market growth with their large patient populations and expanding healthcare infrastructure. The adoption of advanced wound care products and technologies is also on the rise, supported by government initiatives and increasing healthcare expenditure.
North America is projected to have the highest CAGR over the forecast period, owing to its advanced healthcare infrastructure. The U.S. and Canada lead the market with significant investments in research and development of innovative wound care products and technologies. Strong reimbursement policies, widespread awareness, and the presence of key market players further support growth. Further, aging population along with high prevalence of diabetes and obesity in the region fuels the market growth.
Key players in the market
Some of the key players profiled in the Chronic Wound Care Market include The chronic wound care market includes a range of companies such as 3M Healthcare Company, Johnson & Johnson, Smith & Nephew PLC, Mimedx Group, Integra LifeSciences, Molnlycke Health Care, ConvaTec Group plc, Coloplast A/S, Medline Industries Inc., MPM Medical Inc., Organogenesis Inc., Hollister Incorporated, B. Braun Melsungen AG, Hartmann Group, and Medtronic PLC.
In May 2023, 3M has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. (""Pierrel""), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In January 2023, Mimedx entered into an exclusive distribution agreement with Gunze Medical Limited to sell placental tissue allograft, Epifix for wound healing in Japan. Upon this agreement, the company aims at strengthening its position in the Japan market.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.